Showing results (441-450 of 478) with videos related to
Sort By:
Pageof 48
American Journal of Clinical Oncology|February 5, 2011
Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastasesLincy S Lal, Stacey DaCosta Byfield, Eric L Chang, et al.The Journal of Communicable Diseases|November 4, 2006
Entomological indices of Aedes aegypti at some international airports and seaports of southern India--a reportS N Sharma, S Kumar, B P Das, et al.BMC Health Services Research|July 22, 2020
The evaluation of comprehensive medication management for chronic diseases in primary care clinics, a Texas delivery system reform incentive payment programTong Han Chung, Ricardo J Hernandez, Anaelle Libaud-Moal, et al.The Oncologist|May 6, 2021
The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint InhibitorsSaby George, Elizabeth J Bell, Ying Zheng, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|March 29, 2019
The usefulness of trained field workers in diagnosis of post-kala-azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of BiharVidya N R Das, Niyamat A Siddiqui, Krishna Pandey, et al.Clinical Nutrition ESPEN|August 11, 2024
Quality-of-care standards in adult type 3 intestinal failure caused by benign disease: A European society of clinical nutrition and metabolism (ESPEN) position paperS Lal, M Soop, C Cuerda, et al.Arthritis Care & Research|June 20, 2020
Treatment Sequences After Discontinuing a Tumor Necrosis Factor Inhibitor in Patients With Rheumatoid Arthritis: A Comparison of Cycling Versus Swapping StrategiesAliza R Karpes Matusevich, Zhigang Duan, Hui Zhao, et al.Journal of Psychiatry & Neuroscience : JPN|April 23, 1999
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variabilityR Joober, C Benkelfat, K Brisebois, et al.The Oncologist|November 20, 2024
Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitorsJarushka Naidoo, Douglas B Johnson, Charlotte Doran, et al.The Journal of Infection|November 5, 2005
Visceral leishmaniasis (kala-azar)--the Bihar (India) perspectiveP K Sinha, A Ranjan, V P Singh, et al.Pageof 48